U.S. spot Ethereum ETFs command $20.66 billion in ETH, or 4.64% of its market cap. Bitcoin investment product inflows have ...

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

Ozak AI is at stage four of its presale, and this is a very affordable point of entry at a relatively low price of only 0.005 ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

After months of behind-the-scenes action, Litecoin, Bitcoin’s little sister, might be ready to make a major splash. Litecoin ...

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

CoinGlass derivatives data show that the Open Interest (OI) for LTC has increased by 9.52% over the last 24 hours, reaching ...